Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska-Kuczko, Aleksandra Kicman, Eberhard Schlicker
International Journal of Molecular Sciences, doi:10.3390/ijms22041986
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ dysfunction. In this review, we present advantages and disadvantages of cannabidiol (CBD), a non-intoxicating phytocannabinoid from the cannabis plant, as a potential agent for the treatment of COVID-19. CBD has been shown to downregulate proteins responsible for viral entry and to inhibit SARS-CoV-2 replication. Preclinical studies have demonstrated its effectiveness against diseases of the respiratory system as well as its cardioprotective, nephroprotective, hepatoprotective, neuroprotective and anti-convulsant properties, that is, effects that may be beneficial for COVID-19. Only the latter two properties have been demonstrated in clinical studies, which also revealed anxiolytic and antinociceptive effects of CBD (given alone or together with ∆ 9 -tetrahydrocannabinol), which may be important for an adjuvant treatment to improve the quality of life in patients with COVID-19 and to limit post-traumatic stress symptoms. However, one should be aware of side effects of CBD (which are rarely serious), drug interactions (also extending to drugs acting against COVID-19) and the proper route of its administration (vaping may be dangerous). Clearly, further clinical studies are necessary to prove the suitability of CBD for the treatment of COVID-19.
References
Abdallah, Smith, Ware, Moore, Li et al., Effect of vaporized cannabis on exertional breathlessness and exercise endurance in advanced chronic obstructive pulmonary disease. A Randomized Controlled Trial, Ann. Am. Thorac. Soc,
doi:10.1513/AnnalsATS.201803-198OCAdapa, Gayam, Konala, Annangi, Raju et al., Cannabis vaping-induced acute pulmonary toxicity: Case series and review of literature, J. Investig. Med. High. Impact Case Rep,
doi:10.1177/2324709620947267Alenina, Bader, ACE2 in brain physiology and pathophysiology: Evidence from transgenic animal models, Neurochem. Res,
doi:10.1007/s11064-018-2679-4Allsop, Copeland, Lintzeris, Dunlop, Montebello et al., Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial, JAMA Psychiatry,
doi:10.1001/jamapsychiatry.2013.3947Appiah-Kusi, Petros, Wilson, Colizzi, Bossong et al., Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis, Psychopharmacology,
doi:10.1007/s00213-019-05442-6Arendse, Danser, Poglitsch, Touyz, Burnett et al., Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure, Pharmacol. Rev,
doi:10.1124/pr.118.017129Arkell, Lintzeris, Kevin, Ramaekers, Vandrey et al., Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition, Psychopharmacology,
doi:10.1007/s00213-019-05246-8Arruza, Pazos, Mohammed, Escribano, Lafuente et al., Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets, Pediatr. Res,
doi:10.1038/pr.2017.104Asai, Konno, Ozaki, Otsuka, Vecchione et al., COVID-19 drug discovery using intensive approaches, Int. J. Mol. Sci,
doi:10.3390/ijms21082839Atalay, Gęgotek, Wro Ński, Domigues, Skrzydlewska, Therapeutic application of cannabidiol on UVA and UVB irradiated rat skin. A proteomic study, J. Pharm. Biomed. Anal,
doi:10.1016/j.jpba.2020.113656Atalay, Jarocka-Karpowicz, Skrzydlewska, Antioxidative and anti-inflammatory properties of cannabidiol, Antioxidants,
doi:10.3390/antiox9010021Avraham, Grigoriadis, Poutahidis, Vorobiev, Magen et al., Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice, Br. J. Pharmacol,
doi:10.1111/j.1476-5381.2010.01179.xBaban, Khodadadi, Vaibhav, Marchetti, Riccardi et al., Regulation of innate lymphoid cells in acute kidney injury: Crosstalk between cannabidiol and GILZ, J. Immunol. Res,
doi:10.1155/2020/6056373Baj, Karakuła-Juchnowicz, Teresi Ński, Buszewicz, Ciesielka et al., Specific and non-specific clinical manifestations and symptoms: The current state of knowledge, J. Clin. Med,
doi:10.3390/jcm9061753Baranowska-Kuczko, Kozłowska, Kloza, Sadowska, Kozłowski et al., Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: Modification by hypertension and the potential pharmacological opportunities, J. Hypertens,
doi:10.1097/HJH.0000000000002333Beigel, Tomashek, Dodd, Mehta, Zingman et al., ACTT-1 study group members. Remdesivir for the treatment of Covid-19-final report, N. Engl. J. Med,
doi:10.1056/NEJMoa2007764Bergamaschi, Queiroz, Chagas, De Oliveira, De Martinis et al., Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients, Neuropsychopharmacology,
doi:10.1038/npp.2011.6Bharadwaj, Strawn, Groban, Yamaleyeva, Chappell et al., Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction, Hypertension,
doi:10.1161/HYPERTENSIONAHA.111.179358Biali, Broers, Besson, Demeules, Cannabinoids and COVID-19, Med. Cannabis Cannabinoids
Bielawiec, Harasim-Symbor, Konstantynowicz-Nowicka, Sztolsztener, Chabowski, Chronic cannabidiol administration attenuates skeletal muscle de novo ceramide synthesis pathway and related metabolic effects in a rat model of high-fat diet-induced obesity, Biomolecules,
doi:10.3390/biom10091241Boggs, Surti, Gupta, Gupta, Niciu et al., The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial, Psychopharmacology,
doi:10.1007/s00213-018-4885-9Bonow, Fonarow, O'gara, Yancy, Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality, JAMA Cardiol,
doi:10.1001/jamacardio.2020.1105Bourgonje, Abdulle, Timens, Hillebrands, Navis et al., Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19), J. Pathol,
doi:10.1002/path.5471Britch, Babalonis, Walsh, Cannabidiol: Pharmacology and therapeutic targets, Psychopharmacology
Brown, Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic, Res. Soc. Adm. Pharm,
doi:10.1016/j.sapharm.2020.03.020Burrell, Risvanis, Kubota, Dean, Macdonald et al., Myocardial infarction increases ACE2 expression in rat and humans, Eur. Heart. J,
doi:10.1093/eurheartj/ehi114Cannalire, Stefanelli, Cerchia, Beccari, Pelliccia et al., Entry inhibitors: Small molecules and peptides targeting virus or host cells, Int. J. Mol. Sci,
doi:10.3390/ijms21165707Cao, Lu, Tuo, Liu, Zhang et al., Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism, Lipids. Health. Dis,
doi:10.1186/s12944-019-1145-xCapano, Weaver, Burkman, Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: A prospective cohort study, Postgrad. Med,
doi:10.1080/00325481.2019.1685298Capasso, Borrelli, Aviello, Romano, Scalisi et al., Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice, Br. J. Pharmacol,
doi:10.1038/bjp.2008.177Cassol, Comim, Silva, Hermani, Constantino et al., Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture, Brain Res,
doi:10.1016/j.brainres.2010.06.023Chai, Hu, Zhang, Han, Lu et al., Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection, medRxiv
Cheng, Luo, Wang, Zhang, Wang et al., Kidney disease is associated with in-hospital death of patients with COVID-19, Kidney Int,
doi:10.1016/j.kint.2020.03.005Chesney, Mcguire, Freeman, Strang, Englund, Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products, Ther. Adv. Psychopharmacol,
doi:10.1177/2045125320954992Chueh, Zheng, Hou, Lu, Novel evidence of acute kidney injury in COVID-19, J. Clin. Med,
doi:10.3390/jcm9113547Contin, Mancinelli, Perrone, Sabattini, Mohamed et al., Tetrahydrocannabinol/cannabidiol oromucosal spray in patients with multiple sclerosis: A pilot study on the plasma concentration-effect relationship, Clin. Neuropharmacol,
doi:10.1097/WNF.0000000000000294Coperchini, Chiovato, Croce, Magri, Rotondi, The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system, Cytokine Growth Factor Rev,
doi:10.1016/j.cytogfr.2020.05.003Cortopassi, Warfarin dose adjustment required after cannabidiol initiation and titration, Am. J. Health Syst. Pharm,
doi:10.1093/ajhp/zxaa268Costiniuk, Jenabian, Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?, Cytokine Growth Factor Rev,
doi:10.1016/j.cytogfr.2020.05.008Couch, Cook, Ortori, Barrett, Lund et al., Palmitoylethanolamide and cannabidiol prevent inflammation-induced hyperpermeability of the human gut in vitro and in vivo-A randomized, placebo-controlled, doubleblind controlled trial, Inflamm. Bowel Dis,
doi:10.1093/ibd/izz017Crippa, Derenusson, Ferrari, Wichert-Ana, Duran et al., Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report, J. Psychopharmacol,
doi:10.1177/0269881110379283Crippa, Zuardi, Garrido, Wichert-Ana, Guarnieri et al., Effects of cannabidiol (CBD) on regional cerebral blood flow, Neuropsychopharmacology,
doi:10.1038/sj.npp.1300340Cruces, Díaz, Puga, Erranz, Donoso et al., Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS, Intensive Care. Med,
doi:10.1007/s00134-011-2381-3Devinsky, Cilio, Cross, Fernandez-Ruiz, French et al., Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders, Epilepsia,
doi:10.1111/epi.12631Devinsky, Cross, Laux, Marsh, Miller et al., Cannabidiol in Dravet Syndrome Study Group. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome, N. Engl. J. Med,
doi:10.1056/NEJMoa1611618Devinsky, Patel, Cross, Villanueva, Wirrell et al., Effect of Cannabidiol on drop seizures in the Lennox-Gastaut syndrome, N. Engl. J. Med,
doi:10.1056/NEJMoa1714631Dhaundiyal, Kumari, Jawalekar, Chauhan, Kalra et al., Is highly expressed ACE 2 in pregnant women "a curse" in times of COVID-19 pandemic?, Life Sci,
doi:10.1016/j.lfs.2020.118676Domi Ńska, Involvement of ACE2/Ang-(1-7)/MAS1 axis in the regulation of ovarian function in mammals, Int. J. Mol. Sci,
doi:10.3390/ijms21134572Donoghue, Wakimoto, Maguire, Acton, Hales et al., Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins, J. Mol. Cell. Cardiol,
doi:10.1016/S0022-2828(03)00177-9Duan, Beli, Li Calzi, Quigley, Miller et al., Loss of angiotensin-converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction, Stem. Cells,
doi:10.1002/stem.2848Dudášová, Keir, Parsons, Molleman, Page, The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig, Pulm. Pharmacol. Ther,
doi:10.1016/j.pupt.2013.02.002Duran, Pérez, Abanades, Vidal, Saura et al., Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting, Br. J. Clin. Pharmacol,
doi:10.1111/j.1365-2125.2010.03743.xDurst, Danenberg, Gallily, Mechoulam, Meir et al., Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury, Am. J. Physiol. Heart Circ. Physiol,
doi:10.1152/ajpheart.00098.2007Elms, Shannon, Hughes, Lewis, Cannabidiol in the treatment of post-traumatic stress disorder: A case series, J. Altern. Complement. Med,
doi:10.1089/acm.2018.0437Epelman, Shrestha, Troughton, Francis, Sen et al., Soluble angiotensin-converting enzyme 2 in human heart failure: Relation with myocardial function and clinical outcomes, J. Card. Fail,
doi:10.1016/j.cardfail.2009.01.014Esposito, Pesce, Seguella, Sanseverino, Lu et al., The potential of cannabidiol in the COVID-19 pandemic, Br. J. Pharmacol,
doi:10.1111/bph.15157Evans, Rainger, Mason, Guzik, Osto et al., Endothelial dysfunction in COVID-19: A position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science, Cardiovasc. Res,
doi:10.1093/cvr/cvaa230Feng, Chen, Yin, Xia, Liu et al., Effects of cannabidiol on acute reperfused myocardial infarction in rabbits: Evaluated with 3.0T Cardiac Magnetic Resonance Imaging and Histopathology, J. Cardiovasc. Pharmacol,
doi:10.1097/FJC.0000000000000287Feng, Wan, Liu, Zhang, Ma et al., The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer, Oncol. Rep,
doi:10.3892/or_00000718Ferrandi, Alway, Mohamed, The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies, J. Appl. Physiol,
doi:10.1152/japplphysiol.00321.2020Fiani, Sarhadi, Soula, Zafar, Quadri, Current application of cannabidiol (CBD) in the management and treatment of neurological disorders, Neurol. Sci,
doi:10.1007/s10072-020-04514-2Galanopoulos, Gkeros, Doukatas, Karianakis, Pontas et al., COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract, World J. Gastroenterol
Gan, Rosoman, Henshaw, Noble, Georgius et al., COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease, Med. Hypotheses,
doi:10.1016/j.mehy.2020.110024Garduño-Soto, Choreño-Parra, Cazarin-Barrientos, Dermatological aspects of SARS-CoV-2 infection: Mechanisms and manifestations, Arch. Dermatol. Res,
doi:10.1007/s00403-020-02156-0Garg, Royce, Tikellis, Shallue, Batu et al., Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: A novel therapeutic target?, Gut,
doi:10.1136/gutjnl-2019-318512Gemmati, Bramanti, Serino, Secchiero, Zauli et al., COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-Chromosome in males?, Int. J. Mol. Sci,
doi:10.3390/ijms21103474Gheblawi, Wang, Viveiros, Nguyen, Zhong et al., Angiotensin-Converting Enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2, Circ. Res,
doi:10.1161/CIRCRESAHA.120.317015Gilbert, Lamarca, Granger, ACE2 and ANG-(1-7) in the gravid uterus: The new players on the block, Am. J. Physiol. Regul. Integr. Comp. Physiol,
doi:10.1152/ajpregu.00018.2008Gonca, Darici, The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: The role of adenosine A1 receptors, J. Cardiovasc. Pharmacol. Ther,
doi:10.1177/1074248414532013Gonzalez, Orozco-Aguilar, Achiardi, Simon, Cabello-Verrugio, SARS-CoV-2/renin-angiotensin system: Deciphering the clues for a couple with potentially harmful effects on skeletal muscle, Int. J. Mol. Sci,
doi:10.3390/ijms21217904Grambow, Strüder, Klar, Hinz, Vollmar, Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity, BioFactors,
doi:10.1002/biof.1294Greene, Wiley, Yu, Clowers, Craft, Cannabidiol modulation of antinociceptive tolerance to ∆9-Ktetrahydrocannabinol, Psychopharmacology,
doi:10.1007/s00213-018-5036-zGuan, Ni, Hu, Liang, Ou et al., Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med,
doi:10.1056/NEJMoa2002032Gupte, Thatcher, Boustany-Kari, Shoemaker, Yiannikouris et al., Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice, Arterioscler. Thromb. Vasc. Biol,
doi:10.1161/ATVBAHA.112.248559Guzik, Mohiddin, Dimarco, Patel, Savvatis et al., COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options, Cardiovasc. Res,
doi:10.1093/cvr/cvaa106Gáll, Farkas, Albert, Ferencz, Vancea et al., Effects of chronic cannabidiol treatment in the rat chronic unpredictable mild stress model of depression, Biomolecules,
doi:10.3390/biom10050801Hamming, Timens, Bulthuis, Lely, Navis et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J. Pathol,
doi:10.1002/path.1570Haney, Malcolm, Babalonis, Nuzzo, Cooper et al., Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked Cannabis, Neuropsychopharmacology,
doi:10.1038/npp.2015.367Hashimoto, Perlot, Rehman, Trichereau, Ishiguro et al., ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation, Nature,
doi:10.1038/nature11228Haupts, Vila, Jonas, Witte, Álvarez-Ossorio, Influence of previous failed antispasticity therapy on the efficacy and tolerability of THC:CBD oromucosal spray for multiple sclerosis spasticity, Eur. Neurol,
doi:10.1159/000445943Hayakawa, Mishima, Irie, Hazekawa, Mishima et al., Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism, Neuropharmacology,
doi:10.1016/j.neuropharm.2008.06.040He, Liu, Chen, Liu, Cai et al., Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury, Cell. Transplant,
doi:10.3727/096368914X685087He, Zhou, Yu, Wang, Deng et al., Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms, Pharmacol. Res,
doi:10.1016/j.phrs.2020.105224Herbst, Musgrave, Respiratory depression following an accidental overdose of a CBD-labeled product: A pediatric case report, J. Am. Pharm. Assoc,
doi:10.1016/j.japh.2019.09.023Hoggart, Ratcliffe, Ehler, Simpson, Hovorka et al., A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain, J. Neurol,
doi:10.1007/s00415-014-7502-9Holappa, Vapaatalo, Vaajanen, Local ocular renin-angiotensin-aldosterone system: Any connection with intraocular pressure? A comprehensive review, Ann. Med,
doi:10.1080/07853890.2020.1758341Honorato-Sampaio, Andrade, Bader, Martins, Santos et al., Genetic deletion of the Angiotensin-(1-7) receptor Mas leads to a reduced ovulatory rate, Peptides,
doi:10.1016/j.peptides.2018.08.007Horby, Lim, Emberson, Mafham, Bell et al., Dexamethasone in hospitalized patients with Covid-19-Preliminary report, N. Engl. J. Med,
doi:10.1056/NEJMoa2021436Hsu, Painter, Probable interaction between warfarin and inhaled and oral administration of cannabis, J. Pharm. Pract,
doi:10.1177/0897190019854958Hundal, Lister, Evans, Antley, Englund et al., The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group, J. Psychopharmacol,
doi:10.1177/0269881117737400Hunt, East, Lanas, Malfertheiner, Satsangi et al., COVID-19 and gastrointestinal disease. Implications for the gastroenterologist, Dig. Dis,
doi:10.1159/000512152Hurd, Spriggs, Alishayev, Winkel, Gurgov et al., Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial, Am. J. Psychiatry,
doi:10.1176/appi.ajp.2019.18101191Iannotti, Pagano, Moriello, Alvino, Sorrentino et al., Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice, Br. J. Pharmacol,
doi:10.1111/bph.14460Iffland, Grotenhermen, An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies, Cannabis Cannabinoid Res,
doi:10.1089/can.2016.0034Imai, Kuba, Rao, Huan, Guo et al., Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature,
doi:10.1038/nature03712Ingraham, Barakat, Reilkoff, Bezdicek, Schacker et al., Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: A comprehensive review, Eur. Respir. J
Irving, Iqbal, Nwokolo, Subramanian, Bloom et al., A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis, Inflamm. Bowel Dis,
doi:10.1093/ibd/izy002Iwasaki, Saito, Zhao, Sakamoto, Hirota et al., Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: Molecular mechanisms and implications, Inflammation
Janmohamed, Soale, Forastiere, Tang, Sha et al., Intersection of the web-based vaping narrative with COVID-19: Topic modeling study, J. Med. Internet Res,
doi:10.2196/21743Jayarangaiah, Kariyanna, Chen, Jayarangaiah, Kumar, COVID-19-associated coagulopathy: An exacerbated immunothrombosis response, Clin. Appl. Thromb. Hemost,
doi:10.1177/1076029620943293Jiang, Yang, Zhang, Dong, Wang et al., Angiotensin-converting enzyme 2 and angiotensin 1-7: Novel therapeutic targets, Nat. Rev. Cardiol,
doi:10.1038/nrcardio.2014.59Jing, Run-Qian, Hao-Ran, Hao-Ran, Ya-Bin et al., Potential influence of COVID-19/ACE2 on the female reproductive system, Mol. Hum. Reprod,
doi:10.1093/molehr/gaaa030Juan, Gil, Rong, Zhang, Yang et al., Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: Systematic review, Ultrasound Obstet. Gynecol,
doi:10.1002/uog.22088Kangussu, Marzano, Souza, Dantas, Miranda et al., The renin-angiotensin system and the cerebrovascular diseases: Experimental and clinical evidence, Protein Pept. Lett,
doi:10.2174/0929866527666191218091823Karmaus, Wagner, Harkema, Kaminski, Kaplan, Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice, J. Immunotoxicol,
doi:10.3109/1547691X.2012.741628Karschner, Darwin, Goodwin, Wright, Huestis, Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration, Clin. Chem,
doi:10.1373/clinchem.2010.152439Kassiri, Zhong, Guo, Basu, Wang et al., Loss of angiotensinconverting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction, Circ. Heart. Fail,
doi:10.1161/CIRCHEARTFAILURE.108.840124Katsi, Maragkoudakis, Marketou, Tsioufis, Parthenakis et al., The role of angiotensin-(1-7)/Mas axis and angiotensin type 2 receptors in the central nervous system in cardiovascular disease and therapeutics: A riddle to be solved, Curr. Vasc. Pharmacol,
doi:10.2174/1570161117666181105154843Khodadadi, Salles, Jarrahi, Chibane, Costigliola et al., Cannabidiol modulates cytokine storm in acute respiratory distress syndrome induced by simulated viral infection using synthetic RNA, Cannabis Cannabinoid Res,
doi:10.1089/can.2020.0043Kicman, Toczek, The effects of cannabidiol, a non-intoxicating compound of cannabis, on the cardiovascular system in health and disease, Int. J. Mol. Sci,
doi:10.3390/ijms21186740Kimura, Francisco, Conway, Martinez, Vercelli et al., Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells, J. Allergy. Clin. Immunol,
doi:10.1016/j.jaci.2020.05.004Kochi, Tagliari, Forleo, Fassini, Tondo, Cardiac and arrhythmic complications in patients with COVID-19, J. Cardiovasc. Electrophysiol,
doi:10.1111/jce.14479Konturek, Harsch, Neurath, Zopf, COVID-19 -more than respiratory disease: A gastroenterologist's perspective, J. Physiol. Pharmacol,
doi:10.26402/jpp.2020.2.02Kossakowski, Schlicker, Toczek, Weresa, Malinowska, Cannabidiol affects the Bezold-Jarisch reflex via TRPV1 and 5-HT 3 receptors and has peripheral sympathomimetic effects in spontaneously hypertensive and normotensive rats, Front. Pharmacol,
doi:10.3389/fphar.2019.00500Krueger, Murrell, Garcet, Navrazhina, Lee et al., Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis, J. Allergy Clin. Immunol,
doi:10.1016/j.jaci.2020.09.021Kuba, Imai, Ohto-Nakanishi, Penninger, Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters, Pharmacol. Ther,
doi:10.1016/j.pharmthera.2010.06.003Lafuente, Pazos, Alvarez, Mohammed, Santos et al., Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia, Front. Neurosci,
doi:10.3389/fnins.2016.00323Lazartigues, Qadir, Mauvais-Jarvis, Endocrine significance of SARS-CoV-2's reliance on ACE2, Endocrinology,
doi:10.1210/endocr/bqaa108Lee, Erdelyi, Matyas, Mukhopadhyay, Varga et al., Cannabidiol limits T cell-mediated chronic autoimmune myocarditis: Implications to autoimmune disorders and organ transplantation, Mol. Med,
doi:10.2119/molmed.2016.00007Leweke, Piomelli, Pahlisch, Muhl, Gerth et al., Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia, Transl. Psychiatry,
doi:10.1038/tp.2012.15Li, Feng, Li, Yuece, Lin et al., Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice, Pancreas,
doi:10.1097/MPA.0b013e318259f6f0Li, Wu, Yao, Guo, Liao et al., Caution on kidney dysfunctions of COVID-19 patients, medRxiv
Lichtman, Lux, Mcquade, Rossetti, Sanchez et al., Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain, J. Pain Symptom Manag,
doi:10.1016/j.jpainsymman.2017.09.001Ligresti, De Petrocellis, Di Marzo, Phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology, Physiol. Rev,
doi:10.1152/physrev.00002.2016Liou, Auchampach, Hillard, Zhu, Yousufzai et al., Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor, Invest. Ophthalmol. Vis. Sci,
doi:10.1167/iovs.08-2196Liou, El-Remessy, Ibrahim, Caldwell, Khalifa et al., Cannabidiol as a putative novel therapy for diabetic retinopathy: A postulated mechanism of action as an entry point for biomarker-guided clinical development, Curr. Pharmacogen. Person Med,
doi:10.2174/1875692110907030215Liu, Long, Zhang, Zhang, Chen et al., ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection, Clin. Gastroenterol. Hepatol,
doi:10.1016/j.cgh.2020.04.040Lovren, Pan, Quan, Teoh, Wang et al., Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis, Am. J. Physiol. Heart. Circ. Physiol,
doi:10.1152/ajpheart.00331.2008Luftner, Possinger, Ernst, Ruhstaller, Meissner et al., Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group, J. Clin. Oncol,
doi:10.1200/JCO.2005.05.1847Lumbers, Delforce, Pringle, Smith, The lung, the heart, the novel coronavirus, and the renin-angiotensin system; The need for clinical trials, Front. Med,
doi:10.3389/fmed.2020.00248Lundholm, Poku, Emanuele, Emanuele, Lopez, SARS-CoV-2 (COVID-19) and the endocrine system, J. Endocr. Soc,
doi:10.1210/jendso/bvaa144Luís, Hipólito-Fernandes, Mota, Maleita, Xavier et al., A review of neuro-ophthalmological manifestations of human coronavirus infection, Eye Brain,
doi:10.2147/EB.S268828Machhi, Herskovitz, Senan, Dutta, Nath et al., The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections, J. Neuroimmune Pharmacol,
doi:10.1007/s11481-020-09944-5Makwana, Venkatasamy, Spina, Page, The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough, J. Pharmacol. Expl. Ther,
doi:10.1124/jpet.114.221283Mamber, Krakowka, Osborn, Saberski, Rhodes et al., Can unconventional immunomodulatory agents help alleviate COVID-19 symptoms and severity?, MSphere,
doi:10.1128/mSphere.00288-20Maor, Yu, Kuzontkoski, Dezube, Zhang et al., Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium, Genes. Cancer,
doi:10.1177/1947601912466556Marquez, Wysocki, Pandit, Batlle, An update on ACE2 amplification and its therapeutic potential, Acta. Physiol,
doi:10.1111/apha.13513Marshall, Gohlke, Chambers, Howell, Bottoms et al., Angiotensin II and the fibroproliferative response to acute lung injury, Am. J. Physiol. Lung. Cell. Mol. Physiol,
doi:10.1152/ajplung.00313.2002Marshall, Webb, Bellingan, Montgomery, Chaudhari et al., Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome, Am. J. Respir. Crit. Care. Med,
doi:10.1164/rccm.2108086Mawhirt, Frankel, Diaz, Cutaneous manifestations in adult patients with COVID-19 and dermatologic conditions related to the COVID-19 pandemic in health care workers, Curr. Allergy Asthma Rep,
doi:10.1007/s11882-020-00974-wMcguire, Robson, Cubala, Vasile, Morrison et al., Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial, Am. J. Psychiatry,
doi:10.1176/appi.ajp.2017.17030325Mcnamara, Dang, Sturza, Ziobro, Fedak Romanowski et al., Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid, Epilepsia,
doi:10.1111/epi.16596Mecha, Feliú, Iñigo, Mestre, Carrillo-Salinas et al., Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors, Neurobiol. Dis,
doi:10.1016/j.nbd.2013.06.016Millar, Stone, Bellman, Yates, England et al., A systematic review of cannabidiol dosing in clinical populations, Br. J. Clin. Pharmacol,
doi:10.1111/bcp.14038Miller, Scheffer, Gunning, Sanchez-Carpintero, Gil-Nagel et al., Dose-Ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: A randomized clinical trial, JAMA Neurol,
doi:10.1001/jamaneurol.2020.0073Mishima, Hayakawa, Abe, Ikeda, Egashira et al., Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine 1A receptor-dependent mechanism, Stroke,
doi:10.1161/01.STR.0000163083.59201.34Mukhopadhyay, Rajesh, Horváth, Bátkai, Park et al., Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death, Free Radic. Biol. Med,
doi:10.1016/j.freeradbiomed.2011.02.021Nadarajah, Milagres, Dilauro, Gutsol, Xiao et al., Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice, Kidney Int,
doi:10.1038/ki.2012.83Naftali, Mechulam, Marii, Gabay, Stein et al., Lowdose cannabidiol is safe but not effective in the treatment for Crohn's disease, a randomized controlled trial, Dig. Dis. Sci,
doi:10.1007/s10620-017-4540-zNajjar, Najjar, Chong, Pramanik, Kirsch et al., Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports, J. Neuroinflamm,
doi:10.1186/s12974-020-01896-0Niu, Yang, Lin, Ji, Guo, Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice, Endocrine,
doi:10.1007/s12020-008-9110-xNozato, Yamamoto, Takeshita, Nozato, Imaizumi et al., Angiotensin 1-7 alleviates aging-associated muscle weakness and bone loss, but is not associated with accelerated aging in ACE2-knockout mice, Clin. Sci,
doi:10.1042/CS20190573Oláh, Tóth, Borbíró, Sugawara, Szöllõsi et al., Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes, J. Clin. Invest,
doi:10.1172/JCI64628Osterreicher, Taura, De Minicis, Seki, Penz-Osterreicher et al., Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice, Hepatology,
doi:10.1002/hep.23104Oudit, Kassiri, Patel, Chappell, Butany et al., Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice, Cardiovasc. Res,
doi:10.1016/j.cardiores.2007.04.007Pagano, Capasso, Piscitelli, Romano, Parisi et al., An orally active cannabis extract with high content in cannabidiol attenuates chemically-induced intestinal inflammation and hypermotility in the mouse, Front. Pharmacol,
doi:10.3389/fphar.2016.00341Palmieri, Laurino, Vadalà, A therapeutic effect of CBD-enriched ointment in inflammatory skin diseases and cutaneous scars, Clin. Ter,
doi:10.7417/CT.2019.2116Palumbo, Ávila, Naftolin, The Ovarian Renin-Angiotensin System (OVRAS): A Major Factor in Ovarian Function and Disease, Reprod. Sci,
doi:10.1177/1933719116672588Pan, Zhan, Le, Zheng, Jin, Angiotensin-converting enzymes play a dominant role in fertility, Int. J. Mol. Sci,
doi:10.3390/ijms141021071Paoli, Gorini, Caprio, The dark side of the spoon-glucose, ketones and COVID-19: A possible role for ketogenic diet?, J. Transl. Med,
doi:10.1186/s12967-020-02600-9Pascolo, Zito, Zupin, Luppi, Giolo et al., Renin angiotensin system, COVID-19 and male fertility: Any risk for conceiving?, Microorganisms,
doi:10.3390/microorganisms8101492Patel, Bodiga, Fan, Das, Wang et al., Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice, Hypertension,
doi:10.1161/HYPERTENSIONAHA.112.191650Patel, Wallis, Fujinami, Wilcox, Smith, Cannabidiol reduces seizures following CNS infection with Theiler's murine encephalomyelitis virus, Epilepsia Open,
doi:10.1002/epi4.12351Patra, Barker-Haliski, White, Whalley, Glyn et al., Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models, Epilepsia,
doi:10.1111/epi.14629Patsalos, Szaflarski, Gidal, Van Landingham, Critchley et al., Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs, Epilepsia,
doi:10.1111/epi.16674Pazos, Mohammed, Lafuente, Santos, Martínez-Pinilla et al., Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT 1A and CB2 receptors, Neuropharmacology,
doi:10.1016/j.neuropharm.2013.03.027Penna, Mercurio, Tocchetti, Pagliaro, Sex-related differences in COVID-19 lethality, Br. J. Pharmacol,
doi:10.1111/bph.15207Pennisi, Lanza, Falzone, Fisicaro, Ferri et al., SARS-CoV-2 and the nervous system: From clinical features to molecular mechanisms, Int. J. Mol. Sci,
doi:10.3390/ijms21155475Petrosino, Verde, Vaia, Allarà, Iuvone et al., Anti-inflammatory properties of cannabidiol, a nonpsychotropic cannabinoid, in experimental allergic contact dermatitis, J. Pharmacol. Exp. Ther,
doi:10.1124/jpet.117.244368Pickering, Semple, Nazir, Murphy, Snow et al., Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety, Chron. Respir. Dis,
doi:10.1177/1479972310391283Pisanti, Malfitano, Ciaglia, Lamberti, Ranieri et al., Cannabidiol: State of the art and new challenges for therapeutic applications, Pharmacol. Ther,
doi:10.1016/j.pharmthera.2017.02.041Pędzi Ńska-Betiuk, Weresa, Schlicker, Harasim-Symbor, Toczek et al., Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart, Toxicol. Appl. Pharmacol,
doi:10.1016/j.taap.2020.115368Rahimi, Tehranchinia, A comprehensive review of cutaneous manifestations associated with COVID-19, Biomed. Res. Int,
doi:10.1155/2020/1236520Raj, Park, Cho, Choi, Kim et al., Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches, Int. J. Biol. Macromol,
doi:10.1016/j.ijbiomac.2020.12.020Rajesh, Mukhopadhyay, Bátkai, Patel, Saito et al., Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy, J. Am. Coll. Cardiol,
doi:10.1016/j.jacc.2010.07.033Reis, Reis, Angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) and Mas receptor in gonadal and reproductive functions, Clin. Sci (Lond),
doi:10.1042/CS20200865Remiszewski, Jarocka-Karpowicz, Biernacki, Jastrz Ąb, Schlicker et al., Chronic Cannabidiol administration fails to diminish blood pressure in rats with primary and secondary hypertension despite its effects on cardiac and plasma endocannabinoid system, oxidative stress and lipid metabolism, Int. J. Mol. Sci,
doi:10.3390/ijms21041295Rey-Parra, Vadivel, Coltan, Hall, Eaton et al., Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury, J. Mol. Med,
doi:10.1007/s00109-012-0859-2Ribeiro, Almeida, Costola De, Souza, Ferraz De Paula et al., Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury, Immunopharmacol. Immunotoxicol,
doi:10.3109/08923973.2014.976794Ribeiro, Ferraz-De-Paula, Pinheiro, Vitoretti, Mariano-Souza et al., Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor, Eur. J. Pharmacol,
doi:10.1016/j.ejphar.2011.12.043Rock, Sullivan, Collins, Goodman, Limebeer et al., Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews, Psychopharmacology,
doi:10.1007/s00213-020-05559-zRossi, Tortora, Argenziano, Di Paola, Punzo, Cannabinoid receptor type 2: A possible target in SARS-CoV-2 (CoV-19) infection?, Int. J. Mol. Sci,
doi:10.3390/ijms21113809Ruiz-Valdepeñas, Martínez-Orgado, Benito, Millán, Tolón et al., Cannabidiol reduces lipopolysaccharideinduced vascular changes and inflammation in the mouse brain: An intravital microscopy study, J. Neuroinflamm,
doi:10.1186/1742-2094-8-5Russo, Naro, Leo, Sessa, D'aleo et al., Evaluating Sativex®in neuropathic pain management: A clinical and neurophysiological assessment in multiple sclerosis, Pain Med,
doi:10.1093/pm/pnv080Sadowska, Baranowska-Kuczko, Gromotowicz-Popławska, Biernacki, Kicman et al., Cannabidiol ameliorates monocrotaline-induced pulmonary hypertension in rats, Int. J. Mol. Sci,
doi:10.3390/ijms21197077Sahara, Ikutomi, Morita, Minami, Nakajima et al., Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation, Cardiovasc. Res
Salles, Khodadadi, Jarrahi, Ahluwalia, Paffaro et al., Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome, J. Cell. Mol. Med
Samidurai, Das, Cardiovascular Complications associated with COVID-19 and potential therapeutic strategies, Int. J. Mol. Sci,
doi:10.3390/ijms21186790Sampaio, Nascimento, Santos, Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats, Am. J. Physiol. Heart. Circ. Physiol,
doi:10.1152/ajpheart.01145.2002Santos, Guimarães, Crippa, Hallak, Rossi et al., Serious adverse effects of cannabidiol (CBD): A review of randomized controlled trials, Expert Opin. Drug Metab. Toxicol,
doi:10.1080/17425255.2020.1754793Santos, Sampaio, Alzamora, Motta-Santos, Alenina et al., The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system: Focus on Angiotensin-(1-7), Physiol. Rev,
doi:10.1152/physrev.00023.2016Saponaro, Rutigliano, Sestito, Bandini, Storti et al., ACE2 in the era of SARS-CoV-2: Controversies and novel perspectives, Front. Mol. Biosci,
doi:10.3389/fmolb.2020.588618Sawalha, Zhao, Coit, Lu, Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients, medRxiv,
doi:10.1016/j.clim.2020.108410Selvarajah, Gandhi, Emery, Tesfaye, Randomized placebo-controlled double-blind clinical trial of cannabisbased medicinal product (Sativex) in painful diabetic neuropathy: Depression is a major confounding factor, Diabetes Care,
doi:10.2337/dc09-1029Sexton, Cannabis in the time of coronavirus disease 2019: The Yin and Yang of the endocannabinoid system in immunocompetence, J. Altern. Complement. Med,
doi:10.1089/acm.2020.0144Shan, Shang, Zhang, Zhao, Chen et al., Effect of angiotensin-(1-7) and angiotensin II on the proliferation and activation of human endometrial stromal cells in vitro, Int. J. Clin. Exp. Pathol
Shannon, Lewis, Lee, Hughes, Cannabidiol in anxiety and sleep: A large case series, Perm. J,
doi:10.7812/TPP/18-041Sharma, Stevens, Obukhov, Grant, Oudit et al., ACE2 (angiotensin-converting enzyme 2) in cardiopulmonary diseases: Ramifications for the control of SARS-CoV-2, Hypertension,
doi:10.1161/HYPERTENSIONAHA.120.15595Shenoy, Kwon, Rathinasabapathy, Lin, Jin et al., Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, Hypertension,
doi:10.1161/HYPERTENSIONAHA.114.03871Shoemaker, Tannock, Su, Gong, Gurley et al., Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice, Biol. Sex. Differ,
doi:10.1186/s13293-019-0260-8Shover, Humphreys, Debunking cannabidiol as a treatment for COVID-19: Time for the FDA to adopt a focused deterrence model?, Cureus,
doi:10.7759/cureus.8671Soares, Vuolo, Dall'igna, Michels, Crippa et al., Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury, Rev. Bras. Ter. Intensiva,
doi:10.5935/0103-507X.20150064Solowij, Broyd, Beale, Prick, Greenwood et al., Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular cannabis users: A pragmatic open-label clinical trial, Cannabis Cannabinoid Res,
doi:10.1089/can.2017.0043Solowij, Broyd, Greenwood, Van Hell, Martelozzo et al., A randomised controlled trial of vaporised ∆9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: Acute intoxication effects, Eur. Arch. Psychiatry Clin. Neurosci,
doi:10.1007/s00406-019-00978-2Somasundaram, Ranathunga, Ratnasamy, Wijewickrama, Dissanayake et al., The impact of SARS-Cov-2 virus infection on the endocrine system, J. Endocr. Soc,
doi:10.1210/jendso/bvaa082Tan, Liao, Zhou, Mei, Wong, Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases, Curr. Opin. Pharmacol,
doi:10.1016/j.coph.2017.12.002Tang, Li, Wang, Sun, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J. Thromb. Haemost,
doi:10.1111/jth.14768Thiele, Marsh, French, Mazurkiewicz-Beldzinska, Benbadis et al., Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial, Lancet,
doi:10.1016/S0140-6736(18)30136-3Tikellis, Thomas, Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease, Int. J. Pept,
doi:10.1155/2012/256294Tu, Chien, Yarmishyn, Lin, Luo et al., A review of SARS-CoV-2 and the ongoing clinical trials, Int. J. Mol. Sci,
doi:10.3390/ijms21072657Van De Donk, Niesters, Kowal, Olofsen, Dahan et al., An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia, Pain,
doi:10.1097/j.pain.0000000000001464Varatharaj, Thomas, Ellul, Davies, Pollak et al., Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study, Lancet Psychiatry,
doi:10.1016/S2215-0366(20)30287-XVerdecchia, Cavallini, Spanevello, Angeli, COVID-19: ACE2centric infective disease?, Hypertension
Verma, Shan, Lei, Yuan, Liu et al., ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy, Mol. Ther,
doi:10.1038/mt.2011.155Verma, Xu, Du, Zhu, Liang et al., Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice, Mol. Ther. Methods. Clin. Dev,
doi:10.1016/j.omtm.2019.06.007Vilela, Gomides, David, Antunes, Diniz et al., Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine, Mediators Inflamm,
doi:10.1155/2015/523418Vilela, Lima, Kunsch, Pinto, De Miranda et al., Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels, Epilepsy Behav,
doi:10.1016/j.yebeh.2017.07.014Vuolo, Abreu, Michels, Xisto, Blanco et al., Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma, Eur. J. Pharmacol
Vuolo, Petronilho, Sonai, Ritter, Hallak et al., Evaluation of serum cytokines levels and the role of cannabidiol treatment in animal model of asthma, Mediators Inflamm,
doi:10.1155/2015/538670Wade, Makela, House, Bateman, Robson, Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis, Mult. Scler,
doi:10.1177/1352458505070618Wade, Makela, Robson, House, Bateman, Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients, Mult. Scler,
doi:10.1191/1352458504ms1082oaWalsh, Hepburn, Kane, Wainwright, Acute administration of cannabidiol in vivo suppresses ischaemiainduced cardiac arrhythmias and reduces infarct size when given at reperfusion, Br. J. Pharmacol,
doi:10.1111/j.1476-5381.2010.00755.xWang, Kovalchuk, Li, Rodriguez-Juarez, Ilnytskyy et al., In search of preventive strategies: Novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues, Aging
Wang, Mukhopadhyay, Cao, Wang, Feng et al., Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury, Sci. Rep,
doi:10.1038/s41598-017-10924-8Weisberg, Sattler, Yang, Parent, Gray et al., Current therapies under investigation for COVID-19: Potential COVID-19 treatments, Can. J. Physiol. Pharmacol,
doi:10.1139/cjpp-2020-0286Wheal, Jadoon, Randall, O'sullivan, In Vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of zucker diabetic fatty rats, Front. Pharmacol,
doi:10.3389/fphar.2017.00248Wilson, Bossong, Appiah-Kusi, Petros, Brammer et al., Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis, Transl. Psychiatry,
doi:10.1038/s41398-019-0534-2Wilson-Morkeh, Al-Abdulla, Sien, Mohamed, Youngstein, Important drug interactions exist between cannabidiol oil and commonly prescribed drugs in rheumatology practice, Rheumatology,
doi:10.1093/rheumatology/kez304Xiao, Gao, Lazartigues, Zucker, Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure, Hypertension,
doi:10.1161/HYPERTENSIONAHA.111.176636Xue, Mi, Wang, Pang, Liu et al., High expression of ACE2 on keratinocytes reveals skin as a potential target for SARS-CoV-2, J. Invest. Dermatol,
doi:10.1016/j.jid.2020.05.087Yamaleyeva, Pulgar, Lindsey, Yamane, Varagic et al., Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity, Am. J. Physiol. Endocrinol. Metab,
doi:10.1152/ajpendo.00596.2014Yamamoto, Ohishi, Katsuya, Ito, Ikushima et al., Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II, Hypertension,
doi:10.1161/01.HYP.0000205833.89478.5bZheng, Feng, Liu, Targher, Byrne et al., Extrapulmonary complications of COVID-19: A multisystem disease?, J. Med. Virol,
doi:10.1002/jmv.26294Zhong, Basu, Guo, Chow, Byrns et al., Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction, Circulation,
doi:10.1161/CIRCULATIONAHA.110.955369Zhou, Kang, Li, Zhao, Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms, J. Neurol,
doi:10.1007/s00415-020-09929-7Zhu, Verma, Prasad, Li, Expression and function of Mas-related G Protein-Coupled Receptor D and its ligand alamandine in retina, Mol. Neurobiol,
doi:10.1007/s12035-019-01716-4Zorzenon, Santiago, Mori, Piovan, Jansen et al., Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion, Chem. Biol. Interact,
doi:10.1016/j.cbi.2019.108819Zuardi, Cosme, Graeff, Guimarães, Effects of ipsapirone and cannabidiol on human experimental anxiety, J. Psychopharmacol,
doi:10.1177/026988119300700112Zuardi, Rodrigues, Silva, Bernardo, Hallak et al., Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life, Front. Pharmacol,
doi:10.3389/fphar.2017.00259Ąsecka, Borovac, Guerreiro, Giustozzi, Parker et al., Thrombotic complications in patients with COVID-19: Pathophysiological mechanisms, diagnosis, and treatment, Cardiovasc. Drugs Ther,
doi:10.1007/s10557-020-07084-9
